These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 24771510

  • 1. Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism.
    Hui KF, Chiang AK.
    Int J Cancer; 2014 Dec 15; 135(12):2950-61. PubMed ID: 24771510
    [Abstract] [Full Text] [Related]

  • 2. Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.
    Hui KF, Lam BH, Ho DN, Tsao SW, Chiang AK.
    Mol Cancer Ther; 2013 May 15; 12(5):747-58. PubMed ID: 23475956
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir.
    Hui KF, Cheung AK, Choi CK, Yeung PL, Middeldorp JM, Lung ML, Tsao SW, Chiang AK.
    Int J Cancer; 2016 Jan 01; 138(1):125-36. PubMed ID: 26205347
    [Abstract] [Full Text] [Related]

  • 4. Histone deacetylase inhibitor depsipeptide (FK228) induces apoptosis in leukemic cells by facilitating mitochondrial translocation of Bax, which is enhanced by the proteasome inhibitor bortezomib.
    Sutheesophon K, Kobayashi Y, Takatoku MA, Ozawa K, Kano Y, Ishii H, Furukawa Y.
    Acta Haematol; 2006 Jan 01; 115(1-2):78-90. PubMed ID: 16424655
    [Abstract] [Full Text] [Related]

  • 5. The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism.
    Buglio D, Mamidipudi V, Khaskhely NM, Brady H, Heise C, Besterman J, Martell RE, MacBeth K, Younes A.
    Br J Haematol; 2010 Nov 01; 151(4):387-96. PubMed ID: 20880107
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.
    Karthik S, Sankar R, Varunkumar K, Ravikumar V.
    Biomed Pharmacother; 2014 Apr 01; 68(3):327-34. PubMed ID: 24485799
    [Abstract] [Full Text] [Related]

  • 9. Blocking NF-κB sensitizes non-small cell lung cancer cells to histone deacetylase inhibitor induced extrinsic apoptosis through generation of reactive oxygen species.
    Karthik S, Sankar R, Varunkumar K, Anusha C, Ravikumar V.
    Biomed Pharmacother; 2015 Feb 01; 69():337-44. PubMed ID: 25661379
    [Abstract] [Full Text] [Related]

  • 10. Targeting the integrated networks of aggresome formation, proteasome, and autophagy potentiates ER stress‑mediated cell death in multiple myeloma cells.
    Moriya S, Komatsu S, Yamasaki K, Kawai Y, Kokuba H, Hirota A, Che XF, Inazu M, Gotoh A, Hiramoto M, Miyazawa K.
    Int J Oncol; 2015 Feb 01; 46(2):474-86. PubMed ID: 25422130
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proteasome inhibitor PS-341 induces apoptosis through induction of endoplasmic reticulum stress-reactive oxygen species in head and neck squamous cell carcinoma cells.
    Fribley A, Zeng Q, Wang CY.
    Mol Cell Biol; 2004 Nov 01; 24(22):9695-704. PubMed ID: 15509775
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aggresome disruption: a novel strategy to enhance bortezomib-induced apoptosis in pancreatic cancer cells.
    Nawrocki ST, Carew JS, Pino MS, Highshaw RA, Andtbacka RH, Dunner K, Pal A, Bornmann WG, Chiao PJ, Huang P, Xiong H, Abbruzzese JL, McConkey DJ.
    Cancer Res; 2006 Apr 01; 66(7):3773-81. PubMed ID: 16585204
    [Abstract] [Full Text] [Related]

  • 15. Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma.
    Santo L, Hideshima T, Kung AL, Tseng JC, Tamang D, Yang M, Jarpe M, van Duzer JH, Mazitschek R, Ogier WC, Cirstea D, Rodig S, Eda H, Scullen T, Canavese M, Bradner J, Anderson KC, Jones SS, Raje N.
    Blood; 2012 Mar 15; 119(11):2579-89. PubMed ID: 22262760
    [Abstract] [Full Text] [Related]

  • 16. A novel hydroxysuberamide derivative potentiates MG132-mediated anticancer activity against human hormone refractory prostate cancers--the role of histone deacetylase and endoplasmic reticulum stress.
    Chen YC, Huang WJ, Hsu JL, Yu CC, Wang WT, Guh JH.
    Prostate; 2013 Sep 15; 73(12):1270-80. PubMed ID: 23813634
    [Abstract] [Full Text] [Related]

  • 17. Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells.
    Sato A, Asano T, Isono M, Ito K, Asano T.
    BMC Urol; 2014 Aug 30; 14():71. PubMed ID: 25176354
    [Abstract] [Full Text] [Related]

  • 18. HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo.
    Huang H, Liu N, Yang C, Liao S, Guo H, Zhao K, Li X, Liu S, Guan L, Liu C, Xu L, Zhang C, Song W, Li B, Tang P, Dou QP, Liu J.
    PLoS One; 2012 Aug 30; 7(12):e52576. PubMed ID: 23285100
    [Abstract] [Full Text] [Related]

  • 19. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.
    Gatti L, Benedetti V, De Cesare M, Corna E, Cincinelli R, Zaffaroni N, Zunino F, Perego P.
    J Inorg Biochem; 2012 Aug 30; 113():94-101. PubMed ID: 22717676
    [Abstract] [Full Text] [Related]

  • 20. Interactions between bortezomib and romidepsin and belinostat in chronic lymphocytic leukemia cells.
    Dai Y, Chen S, Kramer LB, Funk VL, Dent P, Grant S.
    Clin Cancer Res; 2008 Jan 15; 14(2):549-58. PubMed ID: 18223231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.